Press Releases Media Partner PHARMAP 2027 Addresses the Future of Pharmaceutical Manufact... Senior pharma professionals gather in Berlin on 19-20 April for the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2027
Event Partner Content RNA-Targeted Small Molecules: From Discovery to Clinic Leading pharma, biotech and academic experts discuss the future of RNA therapeutics.
Event Partner Content Novel CNS Biomarkers Summit Europe Europe is rapidly becoming a hub for next-generation CNS biomarker innovation
Event Partner Content 4th Cell Therapy for Autoimmune Disease Summit Developers are racing to overcome challenges around safety, scalability, durability of response, and patient access
Event Partner Content 10th Complement-Based Drug Development Summit Uniting leaders pioneering complement-targeted therapies across ophthalmology, neurodegeneration, nephrology, oncology and autoimmune indications
Event Partner Content Better Antifibrotic Decisions Through Cross-Organ Insights The 10th Antifibrotic Drug Development Summit is the industry's only dedicated forum focused on cross-indication antifibrotic drug development
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.